Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series

BACKGROUND: Following recent approval of pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients awaiting lung transplantation (LTx). METHODS: Safety and efficacy of antifibrotic drugs in IPF patients undergoing LTx were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Delanote, Isabelle, Wuyts, Wim A., Yserbyt, Jonas, Verbeken, Eric K., Verleden, Geert M., Vos, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116160/
https://www.ncbi.nlm.nih.gov/pubmed/27863518
http://dx.doi.org/10.1186/s12890-016-0308-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116160/
https://www.ncbi.nlm.nih.gov/pubmed/27863518
http://dx.doi.org/10.1186/s12890-016-0308-z

Ejemplares similares